Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SGLT 2 Inhibitors”

339 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 339 results

Large-scale testing (Phase 3)Active Not RecruitingNCT07214818
What this trial is testing

SGLT2 Inhibitors in Adult Primary Nephrotic Syndrome

Who this might be right for
Nephrotic Syndrome
Mansoura University 75
Post-approval studies (Phase 4)Looking for participantsNCT07292909
What this trial is testing

Effect of Empagliflozin on Inflammation

Who this might be right for
CAD - Coronary Artery DiseaseInflamationPCI+1 more
Hotel Dieu de France Hospital 100
Not applicableStudy completedNCT02966626
What this trial is testing

A Real World Experience of Dapagliflozin in Type 2 Diabetes

Who this might be right for
Type2 Diabetes
University of Malaya 223
Large-scale testing (Phase 3)Active Not RecruitingNCT05505994
What this trial is testing

The Efficacy and Safety of DWP16001 in Combination With Metformin in T2DM Patients Inadequately Controlled on Metformin

Who this might be right for
Diabetes MellitusDiabetes Mellitus, Type 2Glucose Metabolism Disorders+2 more
Daewoong Pharmaceutical Co. LTD. 340
Large-scale testing (Phase 3)Study completedNCT04213677
What this trial is testing

Dapagliflozin Efficacy and Action in PCOS

Who this might be right for
Polycystic Ovary Syndrome
Nanfang Hospital, Southern Medical University 165
Testing effectiveness (Phase 2)WithdrawnNCT04143581
What this trial is testing

SGLT2 Inhibitors in Glomerular Hyperfiltration

Who this might be right for
ObesityNon-diabetic Chronic Kidney Disease
Mario Negri Institute for Pharmacological Research
Not applicableStudy completedNCT05943899
What this trial is testing

Effect of SGLT-2 Inhibitors in Patients With T2DM and Moderate to Severe Liver Fibrosis

Who this might be right for
Type2diabetes
Diabetes Foundation, India 60
Not applicableUnknownNCT03917758
What this trial is testing

Antidiuretic Function Before and During Treatment With SGLT2 Inhibitors

Who this might be right for
Diabetes Mellitus, Type 2Arterial HypertensionBody Weight Changes
University of Turin, Italy 30
Not applicableLooking for participantsNCT07379788
What this trial is testing

ARNI Combined With SGLT2 Inhibitors on Functional Mitral Regurgitation Remodeling

Who this might be right for
Heart Failure
Rehab Werida 180
Testing effectiveness (Phase 2)Looking for participantsNCT07239011
What this trial is testing

Dapagliflozin in Depression

Who this might be right for
Depression
Tanta University 60
Post-approval studies (Phase 4)UnknownNCT03631134
What this trial is testing

Effect of SGLT2 Inhibitor on Blood Glucose Profile in Type 2 Diabetic Patients Using Basal Insulin

Who this might be right for
Type2 Diabetes
Nanjing First Hospital, Nanjing Medical University 100
Large-scale testing (Phase 3)Ended earlyNCT03933956
What this trial is testing

Metabolic Effects of the SGLT-2 Inhibitor Empagliflozin in Patients With Diabetic Nephropathy (MEDiaN)

Who this might be right for
Diabetic Nephropathies
Singapore General Hospital 2
Post-approval studies (Phase 4)UnknownNCT02719756
What this trial is testing

Effect of SGLT-2 Inhibitor Dapagliflozin on Glycemic Variability in Patients With Diabetes Mellitus Type 2

Who this might be right for
Diabetes MellitusHypoglycemic Episodes
Research Clinical Centre of the Russian Railways, JSC 100
Large-scale testing (Phase 3)Looking for participantsNCT06217302
What this trial is testing

Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease

Who this might be right for
Diabetic NephropathiesKidney Failure, ChronicDiabetes Mellitus Type 1+1 more
Alessandro Doria 150
Post-approval studies (Phase 4)UnknownNCT04340908
What this trial is testing

Effects of SGLT2 Inhibitor on Type 2 Diabetic Patients Undergoing Cardiac Surgery

Who this might be right for
Diabetes Mellitus, Type 2Cardiac Surgery
Hongchang Guo 500
Post-approval studies (Phase 4)Not Yet RecruitingNCT07108985
What this trial is testing

Effect of Add-on SGLT2i, TZD, or Combination Therapy in Type 2 Diabetes Patients on DPP4 Inhibitors

Who this might be right for
Diabetes Mellitus, Type 2HyperglycemiaInsulin Resistance
Yonsei University 100
Not applicableStudy completedNCT03422263
What this trial is testing

Performance Under SGLT-2-Inhibitors in Humans

Who this might be right for
Diabetes Mellitus, Type 2
Berner Klinik Montana 450
Testing effectiveness (Phase 2)Looking for participantsNCT07174687
What this trial is testing

SGLT2 Inhibitors in Geographic Atrophy

Who this might be right for
Retinal DegenerationRetinal DiseasesEye Diseases+2 more
Washington University School of Medicine 70
Testing effectiveness (Phase 2)Study completedNCT01022112
What this trial is testing

An Efficacy, Safety, and Tolerability Study for TA-7284 in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
Tanabe Pharma Corporation 383
Not applicableStudy completedNCT03200782
What this trial is testing

Postprandial Hypoglycemia in Patients After Bariatric Surgery With Empagliflozin and Anakinra - The Hypo-BEAR-Study

Who this might be right for
Postprandial HypoglycemiaBariatric SurgeryLate Dumping Syndrome
University Hospital, Basel, Switzerland 12
Load More Results